CTI BioPharma Corp Earning Date (CTIC)

USA |NASDAQ |USD

CTIC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 10, 2022 Sep 2022 - - $-0.26
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 10, 2022 Sep 2022 - - $0.00

Cti Biopharma Corp's next earnings date is Thursday, Nov 10, 2022 for the fiscal quarter ending Sep 2022.

CTIC Earnings Date & History Chart

CTIC Earnings & Revenue Forecast

CTIC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 6 $-0.98 $-1.25 $-0.39
Dec 2023 6 $-0.19 $-0.89 $0.45

CTIC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 1 $-0.79 $-0.61 $-0.73
Dec 2023 1 / 1 $-0.19 $0.11 $-0.02

CTIC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 6 $49.66M $30.93M $58.70M
Dec 2023 6 $155.73M $65.41M $289.40M

CTIC Earnings Date & Revenue History

CTIC Earnings History

|
Show More
Show More

CTIC Revenue History

|
Show More
Show More

Cti Biopharma Corp Next Earnings Date & Report

CTIC Next Earnings Date & Report Preview: Sep 2022 (FQ)

CTIC's next earnings date is Thursday, Nov 10, 2022 for the fiscal quarter ending Sep 30, 2022.

Cti Biopharma Corp Previous Earnings Dates & Reports

CTIC Previous Earnings Date & Report Recap: Jun 2022 (FQ)

Cti Biopharma Corp's previous earnings date was Aug 3, 2022 for its fiscal quarter ended Jun 30, 2022.

CTIC Previous Earnings Date & Report Recap: Dec 2021 (FY)

Cti Biopharma Corp's previous annual earnings date was Mar 31, 2022 for its fiscal year ended Dec 31, 2021.

CTIC's earnings per share (EPS) was $-1.08, missing the consensus analysts forecast of $-0.98 by 10.20% , and lower than the previous year's EPS (Dec 2020) by 45.95%.

Revenues were $0.00.

The company reported a net income of $-97.91M.

Cti Biopharma Corp reported a free cash flow of $-84.89M for its fiscal year, compared to $-42.22M a year ago.

The company ended the fiscal year with $47.38M in total debt, an increase of 431.76% compared to the previous year.